LINC03122
Uncharacterized protein encoded by LINC03122
Also known as: CE064_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for LINC03122 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
130 residues, UniProt reviewed canonical sequence.
>Q2M2E5|LINC03122
1 MLAPLFLCCL RNLFRKLISF QPPQLGRTNM HYSKLPRTAI ETEFKQNVGP PPKDLTAEVY
61 FPSIKSRSHL PAVFYNQYFK HPKCVGEYGP KNGAERQIEE RKVLPTTMMF SMLADCVLKS
121 TPIPILGVAMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LINC03122 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LINC03122 as an antibody target. Whether an autoantibody or antibody against LINC03122 could matter depends on whether native LINC03122 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LINC03122 is annotated as secreted, so native LINC03122 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label LINC03122 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...